{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_plasma_exchange",
          "name": "Plasma exchange"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_tacrolimus",
          "name": "Tacrolimus"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_antithrombin_iii",
          "name": "Antithrombin III"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_cangrelor",
          "name": "Cangrelor"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_sirolimus",
          "name": "Sirolimus"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_lenalidomide",
          "name": "Lenalidomide"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_aspirin",
          "name": "Aspirin"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasma_exchange",
          "type": "Drug",
          "label": "Plasma exchange",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_antithrombin_iii",
          "type": "Drug",
          "label": "Antithrombin III",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cangrelor",
          "type": "Drug",
          "label": "Cangrelor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lenalidomide",
          "type": "Drug",
          "label": "Lenalidomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_aspirin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_complement_system",
          "type": "Target",
          "label": "Complement system",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_inflammatory_response",
          "type": "Pathway",
          "label": "Inflammatory response",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_atypical_haemolytic_uraemic_syndrome",
          "type": "Disease",
          "label": "Atypical Haemolytic Uraemic Syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_eculizumab",
          "target": "target_complement_system",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知作用于补体系统的药物"
        },
        {
          "source": "drug_ravulizumab",
          "target": "target_complement_system",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与Eculizumab类似，抑制补体活化"
        },
        {
          "source": "drug_plasma_exchange",
          "target": "pathway_inflammatory_response",
          "relation": "involved_in",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "通过去除致病因子影响炎症反应"
        },
        {
          "source": "drug_corticosteroids",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "常用于调节炎症反应"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "可影响免疫和炎症反应"
        },
        {
          "source": "drug_tacrolimus",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "调节免疫反应，潜在影响炎症"
        },
        {
          "source": "drug_rituximab",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "通过靶向B细胞抑制炎症"
        },
        {
          "source": "drug_antithrombin_iii",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "与炎症和血栓形成的关系"
        },
        {
          "source": "drug_cangrelor",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "影响血小板活性与炎症反应"
        },
        {
          "source": "drug_sirolimus",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "通过免疫抑制影响炎症"
        },
        {
          "source": "drug_lenalidomide",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "有潜在的抗炎特性"
        },
        {
          "source": "drug_aspirin",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "抗炎与止血作用"
        },
        {
          "source": "target_complement_system",
          "target": "disease_atypical_haemolytic_uraemic_syndrome",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "补体系统在该疾病发病机制中起关键作用"
        },
        {
          "source": "pathway_inflammatory_response",
          "target": "disease_atypical_haemolytic_uraemic_syndrome",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "炎症反应与该疾病相关"
        }
      ],
      "set_weights": [
        {
          "edge_id": "e1",
          "weight": 0.85,
          "rationale": "优化后反映强关联"
        },
        {
          "edge_id": "e2",
          "weight": 0.85,
          "rationale": "优化后反映强关联"
        }
      ]
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "Eculizumab 和 Ravulizumab 通过补体系统影响 Atypical Haemolytic Uraemic Syndrome，形成机制链",
        "confidence": "high"
      },
      {
        "id": "C2",
        "text": "多种药物通过炎症通路调节可能与疾病相关",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "所有药物具备到达靶器官的最小暴露（常识判断）"
    ],
    "uncertainties": [
      "单一治疗效果需要临床验证（需后续检验）"
    ],
    "next_focus_for_pi": [
      "是否需比较不同药物的相对效果与安全性？"
    ]
  }
}